Mecamylamine reduces some EEG effects of nicotine chewing gum in humans
- 1 May 1988
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 30 (1) , 149-153
- https://doi.org/10.1016/0091-3057(88)90438-8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The comparative binding characteristics of nicotinic ligands and their pharmacologyPharmacology Biochemistry and Behavior, 1988
- Electroencephalographic effects of nicotine chewing gum in humansPharmacology Biochemistry and Behavior, 1986
- Could Nicotine Antagonists be Used in Smoking Cessation?British Journal of Addiction, 1986
- EEG Changes During Tobacco WithdrawalPsychophysiology, 1983
- Smoking, nicotine and electrocortical activityPharmacology & Therapeutics, 1982
- Central sites and mechanisms of action of nicotineNeuroscience & Biobehavioral Reviews, 1982
- Stereospecific 3H-nicotine binding to intact and solubilized rat brain membranes and evidence for its noncholinergic natureLife Sciences, 1980
- α-Bungarotoxin binding sites in the CNSLife Sciences, 1979
- EEG Alpha Correlates of Non‐Smokers, Smokers, Smoking, and Smoking DeprivationPsychophysiology, 1977
- Quantitative Electroencephalogram in Smoking and Smoking DeprivationScience, 1969